Xstrahl announces a new compact benchtop irradiator designed for cell irradiation in biotech, academia and CROs.
ATLANTA, April 7, 2022 /PRNewswire-PRWeb/ -- Xstrahl, the leader in preclinical radiation research systems, announced today the availability of CIX1, a powerful and intuitive benchtop irradiator designed to make radiation accessible to every research lab. CIX1 is the most advanced benchtop instrument available because of the innovation of the X-ray tube, which provides reliable higher power, a minimal footprint, internal cooling, and no special power requirements.
"CIX1 fits into even the tightest lab spaces and solves the reliability issues associated with current benchtop irradiators, so researchers can irradiate cells 24/7," explained said Adrian Treverton, CEO of Xstrahl. "We listened to our customers and knew that we needed to develop a compact solution to address these accessibility needs and concerns over reliability," he added.
Investigators can place CIX1 directly next to the incubator or hood, minimizing the time cells spend outside of a controlled environment. If there's a high load on existing equipment, CIX1 is the perfect addition because it can be used outside the radiation core or outside the animal barrier. There's no need to fight over schedules or access, or to transport cells to and from the animal housing, saving tremendous effort and time.
CIX1 offers value to every lab because it delivers energy up to 160kVp and is self-contained. CIX1 plugs into a standard outlet with no additional shielding or cooling required. It delivers accurate and repeatable irradiation with both dose and time-based exposure control. Programmable and manual settings provide superior ease-of-use and flexibility, and it comes fully commissioned and ready to go.
Xstrahl delivers a full line of radiation research devices including systems for image-guided radiotherapy and several types of cabinet irradiators. As the only company that delivers both clinical radiation therapy devices and preclinical radiation research systems worldwide, Xstrahl offers unique expertise in R&D specialized in radiation.
Dr. Anthony Chalmers, chair of clinical oncology at the Institute for Cancer Sciences at the University of Glasgow explained: "I have been working with Xstrahl for years, using both the image-guided systems and the cabinet irradiators. Because Xstrahl is involved in both the clinical environment and the research setting, the quality of innovation and practical support are outstanding, especially for researchers with no radiation training. Working with Xstrahl, I feel part of a supportive community of researchers and collaborators worldwide, and am confident that this community is working together to use these devices to make meaningful progress in radiation biology and oncology."
In addition to being powerful, reliable, and efficient, CIX1 also delivers a homogenous dose distribution, providing a much larger useful irradiation area, and the high power is ideal for organoid or tissue slice irradiations.
About Xstrahl
Xstrahl is a medical technology company that designs radiation delivery devices to support clinical teams and cancer researchers. For more than 25 years, Xstrahl has been shaping the development of superficial and orthovoltage radiation therapy and advancing preclinical radiation research. Xstrahl systems are in operation at more than 700 treatment and research facilities worldwide.
Media Contact
Amanda Tulk, Xstrahl, 44 (0) 7977298785, [email protected]
SOURCE Xstrahl
Share this article